|
|
|||
|
||||
OverviewTwo Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the book begins with foundational knowledge of nanovaccines and nanomedicines, detailing their applications in cancer care and highlighting their precision in targeting cancer cells while reducing systemic toxicity. Importantly, the book addresses potential drawbacks, discussing side effects and safety concerns associated with these innovations. The final section emphasizes ethical, regulatory, and safety challenges, underscoring the need for careful oversight as nanotechnologies advance. For the academic audience, this book serves as a vital resource, offering insights that equip researchers and healthcare professionals to make informed decisions regarding clinical applications. Its focus on both benefits and risks, alongside forward-looking perspectives, ensures that readers are well-prepared for future developments in the field of nanomedicine and cancer therapy. Full Product DetailsAuthor: Tuan Anh Nguyen, PhD (Senior Principal Research Scientist, Institute for Tropical Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam) , Bhupendra G. Prajapati, PhD (Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, India) , Devesh U. Kapoor, PhD. (Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, India)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Weight: 0.450kg ISBN: 9780443445798ISBN 10: 0443445796 Pages: 502 Publication Date: 01 April 2026 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Forthcoming Availability: Not yet available This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of ContentsPart 1: Fundamentals 1. Introduction to Nanovaccine 2. Introduction to Nanomedicine 3. Current Perspectives of Nanovaccines and Nanomedicines (in Cancer Treatment) Part 2: Advantage and Application of Nanovaccine and Nanomedicine 4. Advantage of Nanovaccine (in Cancer Treatment) 5. Advantage of Nanomedicine (in Cancer Treatment) 6. Future Perspectives of Nanovaccines and Nanomedicines (in Cancer Treatment) Part 3: The Other Side of Nanovaccine and Nanomedicine 7. Side Effect and Toxicity of Nanovaccine (in Cancer Treatment) 8. Side Effect and Toxicity of Nanomedicine (in Cancer Treatment) Part 4: Challenge and Perspectives 9. Manufacturing on Large Scale Challenges and Issues 10. Ethics in Nanomedicine/Nanovaccines 11. Regulating Nanomedicine/Nanovaccines 12. Safety Assessment for Nanomedicines/NanovaccinesReviewsAuthor InformationTuan Anh Nguyen is a Senior Principal Research Scientist at the Institute for Tropical Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam. He received a BS in physics from Hanoi University in 1992, a BS in economics from Hanoi National Economics University in 1997, and a PhD in chemistry from the Paris Diderot University, France, in 2003. He was a Visiting Scientist at Seoul National University, South Korea, in 2004, and the University of Wollongong, Australia, in 2005. He then worked as a Postdoctoral Research Associate and Research Scientist at Montana State University, United States in 2006-09. In 2012 he was appointed as the Head of the Microanalysis Department at the Institute for Tropical Technology. His research areas of interest include smart sensors, smart networks, smart hospitals, smart cities, complexiverse, and digital twins. He has edited more than 74 books for Elsevier, 12 books for CRC Press, 1 book for Springer, 1 book for RSC, and 2 books for IGI Global. He is the Editor-in-Chief of Kenkyu Journal of Nanotechnology & Nanoscience. Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. He earned his Ph.D. in Pharmaceutical Sciences in 2013 and has over 20 years of academic experience. Dr. Kapoor has published 175+ research and review articles and contributed 50 book chapters. He is currently editing 18 international books with leading publishers and supervises four Ph.D. students in nanodrug delivery and modified release systems. His editorial roles include Associate Editor for Naunyn-Schmiedeberg’s Archives of Pharmacology, PLOS ONE, and several Frontiers journals, and Consulting Editor for Cytotechnology. He has reviewed manuscripts for 135+ journals and holds eight design patents. Dr. Kapoor has secured research and event grants from GUJCOST, GSBTM, and AICTE-ATAL, delivered 20+ invited talks, and actively participates in national conferences and workshops. . Tab Content 6Author Website:Countries AvailableAll regions |
||||